Bonnet Jeremiah, Cernik Colin, Uno Hajime, Xu Lanfang, Laurent Cecile A, Fisher Lauren, Cannizzaro Nancy, Munneke Julie, Cooper Robert M, Lakin Joshua R, Schwartz Corey M, Casperson Mallory, Altschuler Andrea, Kushi Lawrence H, Chao Chun R, Wiener Lori, Mack Jennifer W
Tufts Medical School, Boston, MA.
Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.
JCO Oncol Pract. 2025 May 13:OP2400907. doi: 10.1200/OP-24-00907.
Adolescent and young adult (AYA) patients with cancer frequently receive intensive measures at the end of life; many also express care goals that align with a palliative approach. We sought to understand the extent to which AYAs are referred to palliative care before death, the timing of referrals, and associations between referral timing and end-of-life care outcomes.
Review of electronic health data and medical records for 1,918 AYAs age 12-39 years who died after receiving care at one of the three sites between 2003 and 2019. Patients who received palliative care but lacked documentation of referral timing were excluded.
Most included AYAs were White (61%); 12% were Asian, 8% Black, and 27% Hispanic. Nearly three quarters (73%) were referred to palliative care before death. Thirty-six percent of palliative care referrals took place before the last 90 days of life; 30% were in the last month of life. Palliative care referrals and their timing were associated with care received at the end of life, with earlier referrals associated with fewer intensive measures near death, including chemotherapy in the last 14 days of life ( = .001) as well as intensive care unit admissions, emergency room visits, and hospitalizations in the last month of life ( < .001 for all). Patients who were referred to palliative care were more likely to have symptoms assessed in the last 90 days of life, including pain, dyspnea, nausea, diarrhea, constipation, depression, and anxiety ( < .001 for all).
Although many AYAs receive intensive measures at the end of life, most are also referred to palliative care. Earlier referrals have potential to reduce care intensity and enhance attention to symptoms and quality of life near death.
青少年和青年(AYA)癌症患者在生命末期经常接受强化治疗措施;许多患者还表达了与姑息治疗方法相一致的护理目标。我们试图了解AYA患者在死亡前被转介至姑息治疗的程度、转介时间,以及转介时间与临终护理结果之间的关联。
回顾2003年至2019年间在三个地点之一接受治疗后死亡的1918名12至39岁AYA患者的电子健康数据和病历。排除接受了姑息治疗但缺乏转介时间记录的患者。
纳入的大多数AYA患者为白人(61%);12%为亚洲人,8%为黑人,27%为西班牙裔。近四分之三(73%)的患者在死亡前被转介至姑息治疗。36%的姑息治疗转介发生在生命的最后90天之前;30%发生在生命的最后一个月。姑息治疗转介及其时间与临终时接受的护理相关,较早的转介与死亡前较少的强化治疗措施相关,包括生命最后14天内的化疗(P = 0.001)以及生命最后一个月内的重症监护病房入院、急诊就诊和住院(所有P均<0.001)。被转介至姑息治疗的患者在生命的最后90天内更有可能接受症状评估,包括疼痛、呼吸困难、恶心、腹泻、便秘、抑郁和焦虑(所有P均<0.001)。
尽管许多AYA患者在生命末期接受强化治疗措施,但大多数也被转介至姑息治疗。较早的转介有可能降低治疗强度,并加强对死亡前症状和生活质量的关注。